Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Human Molecular Genetics|October 16, 2007
R91W mutation in Rpe65 leads to milder early-onset retinal dystrophy due to the generation of low levels of 11-cis-retinalMarijana Samardzija, Johannes von Lintig, Naoyuki Tanimoto, et al.
Ophthalmology|August 16, 2017
Sustained Benefits of Ranibizumab with or without Laser in Branch Retinal Vein Occlusion: 24-Month Results of the BRIGHTER StudyRamin Tadayoni, Sebastian M Waldstein, Francesco Boscia, et al.
Clinical Ophthalmology (Auckland, N.Z.)|July 2, 2016
Baseline visual acuity strongly predicts visual acuity gain in patients with diabetic macular edema following anti-vascular endothelial growth factor treatment across trialsPravin U Dugel, Jost Hillenkamp, Sobha Sivaprasad, et al.
Experimental Eye Research|September 6, 2006
The prion protein is neuroprotective against retinal degeneration in vivoRico Frigg, Andreas Wenzel, Marijana Samardzija, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|March 7, 2006
Phenotype of three consanguineous Tunisian families with early-onset retinal degeneration caused by an R91W homozygous mutation in the RPE65 geneLeila El Matri, Aude Ambresin, Daniel F Schorderet, et al.
The British Journal of Ophthalmology|October 11, 2015
Ranibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema: the RETAIN studyChristian Prünte, Franck Fajnkuchen, Sajjad Mahmood, et al.
Ophthalmology|April 4, 2016
Individualized Stabilization Criteria-Driven Ranibizumab versus Laser in Branch Retinal Vein Occlusion: Six-Month Results of BRIGHTERRamin Tadayoni, Sebastian M Waldstein, Francesco Boscia, et al.
Plos Medicine|October 13, 2006
Lentiviral gene transfer of RPE65 rescues survival and function of cones in a mouse model of Leber congenital amaurosisAlexis-Pierre Bemelmans, Corinne Kostic, Sylvain V Crippa, et al.
Ophthalmology Science|January 13, 2025
CANBERRA: A Phase II Randomized Clinical Trial to Test the Therapeutic Potential of Oral Vicasinabin in Diabetic RetinopathyBeatriz G Armendariz, Ulrich F O Luhman, Brian Berger, et al.
The Journal of Biological Chemistry|June 18, 2005
The retinal G protein-coupled receptor (RGR) enhances isomerohydrolase activity independent of lightAndreas Wenzel, Vitus Oberhauser, Edward N Pugh, et al.
Pageof 5